Salarius Pharmaceuticals, Inc. (SLRX)

NASDAQ: SLRX · IEX Real-Time Price · USD

1.830

-0.605 (-24.85%)

At close: Jul 19, 2024, 4:00 PM

1.680

-0.150 (-8.20%)

Pre-market: Jul 22, 2024, 7:24 AM EDT

Salarius Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2015
Net Income	-8.92	-12.54	-31.61	-12.77	-7.75	-6.94	Upgrade
Depreciation & Amortization	0.01	0.01	0.01	0.02	0.02	0.13	Upgrade
Share-Based Compensation	0.4	0.52	0.8	0.56	0.32	0.75	Upgrade
Other Operating Activities	-2.52	-0.84	13.21	1.99	-3.3	-5.52	Upgrade
Operating Cash Flow	-11.03	-12.85	-17.6	-10.2	-10.31	-11.58	Upgrade
Capital Expenditures	0	0	0	0	-0	0	Upgrade
Acquisitions	0	0	-1.5	0	0	5.61	Upgrade
Investing Cash Flow	0	0	-1.5	0	-0	5.61	Upgrade
Dividends Paid	0	0	0	0	0	-0.13	Upgrade
Share Issuance / Repurchase	6.58	6.92	1.99	28.77	14.8	4.13	Upgrade
Debt Issued / Paid	-0.45	-0.28	0	-0.48	-0.97	-0.42	Upgrade
Other Financing Activities	-	-	-	-	3.87	-	Upgrade
Financing Cash Flow	6.13	6.64	1.99	28.3	17.69	3.58	Upgrade
Net Cash Flow	-4.9	-6.21	-17.11	18.1	7.38	-2.39	Upgrade
Free Cash Flow	-11.03	-12.85	-17.6	-10.2	-10.31	-11.58	Upgrade
Free Cash Flow Margin	-	-	-	-554.29%	-197.08%	-334.20%	Upgrade
Free Cash Flow Per Share	-21.04	-31.48	-66.26	-49.32	-132.41	-708.56	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).